Psyence Biomedical Ltd (PBM)
0.653
-0.03
(-4.48%)
USD |
NASDAQ |
Apr 19, 14:28
Psyence Biomedical Shareholders Equity (Quarterly): -0.9774M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.9774M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.9774M
Minimum
Sep 2023
-0.9774M
Maximum
Sep 2023
-0.9774M
Average
-0.9774M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Lucy Scientific Discovery Inc | 0.0812M |
| Lexaria Bioscience Corp | 6.521M |
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.6658M |
| Total Liabilities (Quarterly) | 1.643M |